Recent progress in B- and T-cell lymphomas.
The data we review indicate substantial progress in understanding of the biology of T- and B-cell lymphomas in humans. They indicate how processes central to normal development of B- and T-cells are corrupted in lymphomas and how these abnormalities may be approached or reversed in the context of therapy. Recent progress in treating lymphomas is less striking. The key issues here are whether more intensive therapy is better, whether some persons can be cured with less intensive therapies and whether immune therapies will prove useful. We hope to address these at the next B and T-cell lymphoma meeting scheduled for 1996.